Mapping the Colorectal Cancer Patient Journey From the Oncologist Perspective in Saudi Arabia.
설문조사
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: CRC as surgical (100
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
The most common barrier to effective CRC treatment was delays in patient presentation (67.9%). [CONCLUSION] The results give clinicians and public bodies the opportunity to address critical factors for improving the outcomes for CRC patients in Saudi Arabia.
[PURPOSE] Mapping the colorectal cancer (CRC) patient pathway is needed to identify knowledge gaps and improve patient care.
APA
Alshehri A, Allehebi AO, et al. (2025). Mapping the Colorectal Cancer Patient Journey From the Oncologist Perspective in Saudi Arabia.. Journal of multidisciplinary healthcare, 18, 6699-6718. https://doi.org/10.2147/JMDH.S526377
MLA
Alshehri A, et al.. "Mapping the Colorectal Cancer Patient Journey From the Oncologist Perspective in Saudi Arabia.." Journal of multidisciplinary healthcare, vol. 18, 2025, pp. 6699-6718.
PMID
41111999 ↗
Abstract 한글 요약
[PURPOSE] Mapping the colorectal cancer (CRC) patient pathway is needed to identify knowledge gaps and improve patient care. We aimed to understand the medical journey of patients and the role of the multidisciplinary team (MDT) in managing CRC in Saudi Arabia.
[METHODS] A nationwide survey was administered to healthcare professionals (HCPs) in Saudi Arabia during August 1-September 15, 2024, to characterize typical patient profiles and CRC management.
[RESULTS] Out of 33 responses, 28 were eligible, mostly were medical oncologists (96.4%) in tertiary healthcare settings (>85%) with 5-20 years of experience (78.6%). Most HCPs reported that patients had no or limited awareness of CRC (89.3%) and lacked access to support groups (71.4%). The guideline-recommended screening of individuals aged 45-75 years with no symptoms or a family history of CRC or polyps was only reported by 67.9% of respondents. Common screening methods were colonoscopy (89.3%) and fecal immunochemical test (53.6%). Major barriers to optimal CRC screening were patients' lack of awareness (92.9%) and challenges in accessing screening programs (75.0%). Gastroenterologists were the primary referrers to specialized centers and were responsible for diagnosing CRC (reported by 92.9% and 85.7%, respectively); 53.6% and 17.9% of respondents reported that surgical oncologists and an MDT also made the definitive diagnosis, respectively. Respondents identified the key MDT members taking care of patients with CRC as surgical (100.0%), medical (100.0%), radiation oncologists (92.9%), and pathologists (92.9%). Some MDTs involved other professionals, including radiologists (85.7%), clinical gastroenterologists (64.3%), dieticians (64.3%) and pharmacists (60.7%). The most common barrier to effective CRC treatment was delays in patient presentation (67.9%).
[CONCLUSION] The results give clinicians and public bodies the opportunity to address critical factors for improving the outcomes for CRC patients in Saudi Arabia.
[METHODS] A nationwide survey was administered to healthcare professionals (HCPs) in Saudi Arabia during August 1-September 15, 2024, to characterize typical patient profiles and CRC management.
[RESULTS] Out of 33 responses, 28 were eligible, mostly were medical oncologists (96.4%) in tertiary healthcare settings (>85%) with 5-20 years of experience (78.6%). Most HCPs reported that patients had no or limited awareness of CRC (89.3%) and lacked access to support groups (71.4%). The guideline-recommended screening of individuals aged 45-75 years with no symptoms or a family history of CRC or polyps was only reported by 67.9% of respondents. Common screening methods were colonoscopy (89.3%) and fecal immunochemical test (53.6%). Major barriers to optimal CRC screening were patients' lack of awareness (92.9%) and challenges in accessing screening programs (75.0%). Gastroenterologists were the primary referrers to specialized centers and were responsible for diagnosing CRC (reported by 92.9% and 85.7%, respectively); 53.6% and 17.9% of respondents reported that surgical oncologists and an MDT also made the definitive diagnosis, respectively. Respondents identified the key MDT members taking care of patients with CRC as surgical (100.0%), medical (100.0%), radiation oncologists (92.9%), and pathologists (92.9%). Some MDTs involved other professionals, including radiologists (85.7%), clinical gastroenterologists (64.3%), dieticians (64.3%) and pharmacists (60.7%). The most common barrier to effective CRC treatment was delays in patient presentation (67.9%).
[CONCLUSION] The results give clinicians and public bodies the opportunity to address critical factors for improving the outcomes for CRC patients in Saudi Arabia.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Zolpidem Withdrawal Delirium Developed as Severe Psychiatric and Physical Symptoms in a Patient With a History of Ovarian Cancer: A Case Report and Literature Review.
- Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions.
- Barriers to accessing cancer care services in Eastern Cape and Mpumalanga provinces of South Africa: cancer survivors' perspectives.
- The Role of CRISPR and Its Therapeutic Applications in Glioblastoma.
- The Influence of Blood Brain Barrier Permeability on CSF-To-Serum Ratios of Neurobiomarkers in People With HIV.
- Engineering polysaccharide nanoplatforms for glioblastoma theranostics: Bridging targeted therapy and advanced imaging.